Citadel Advisors’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
NIEF
Citadel Advisors's G Position: Q2 2026 in Review
Citadel Advisors increased its Genpact (G) stake by 2,109% in Q2 2026, buying an estimated $77.8M and bringing the position to 2,478,939 shares worth $68.2M. The position accounts for 0.01% of the portfolio, ranked #1266.
Citadel Advisors first reported a position in G in Q2 2013 and has held it in 46 quarters since. The position peaked at $161M in Q2 2025. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.
- Citadel Advisors held 2,478,939 shares of Genpact worth $68.2M as of Q2 2026.
- Citadel Advisors bought 2,366,740 Genpact shares in Q2 2026, an estimated $77.8M.
- Genpact made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1266 holding.
- Citadel Advisors first reported a position in Genpact in Q2 2013 and has held it in 46 quarters since.
- Citadel Advisors's Genpact position peaked at $161M in Q2 2025.
- 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.